このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

National Health Investors マネジメント

マネジメント基準チェック /44

National Health Investors'の CEO はD. Mendelsohnで、 Aug2015年に任命され、の在任期間は 8.83年です。の年間総報酬は$ 2.08Mで、 24%給与と76%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の0.12%を直接所有しており、その価値は$ 3.63M 。経営陣と取締役会の平均在任期間はそれぞれ6.8年と7.6年です。

主要情報

D. Mendelsohn

最高経営責任者

US$2.1m

報酬総額

CEO給与比率	24.0%
CEO在任期間	8.8yrs
CEOの所有権	0.1%
経営陣の平均在職期間	6.8yrs
取締役会の平均在任期間	7.6yrs

経営陣の近況

Recent updates

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

Feb 21

6%-Yielding National Health Investors: No Pain, No Gain

Feb 06

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Sep 10

National Health Investors Q2 Earnings Preview

Aug 07

National Health Investors: A 5.8% Yield, And Little Else

Jun 29

National Health Investors: Poor Price Growth, Steady Yield, Uncertain Future

Apr 14

National Health Investors: Why This 7% Yielder Is A Buy On The Drop

Feb 06

National Health Management Believes The 6.4% Yield Is Sustainable

Nov 17

National Health Investors: Strong Fundamentals, Low Price, Long-Term Investment

Oct 11

National Health Investors: Buy 'Em When They're Cheap

Sep 26

National Health Investors: The Most Bearish Bull Thesis I Hope To Ever Write

Aug 31

National Health: Not Out Of The Woods Yet

Aug 10

National Health Investors reaches deferral agreement with Bickford

Jun 17

CEO報酬分析

National Health Investors の収益と比較して、D. Mendelsohn の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Mar 31 2024	n/a	n/a	US$132m
Dec 31 2023	US$2m	US$500k	US$136m
Sep 30 2023	n/a	n/a	US$105m
Jun 30 2023	n/a	n/a	US$110m
Mar 31 2023	n/a	n/a	US$92m
Dec 31 2022	US$3m	US$418k	US$66m
Sep 30 2022	n/a	n/a	US$71m
Jun 30 2022	n/a	n/a	US$68m
Mar 31 2022	n/a	n/a	US$85m
Dec 31 2021	US$3m	US$398k	US$112m
Sep 30 2021	n/a	n/a	US$142m
Jun 30 2021	n/a	n/a	US$154m
Mar 31 2021	n/a	n/a	US$159m
Dec 31 2020	US$2m	US$386k	US$185m
Sep 30 2020	n/a	n/a	US$190m
Jun 30 2020	n/a	n/a	US$190m
Mar 31 2020	n/a	n/a	US$186m
Dec 31 2019	US$2m	US$375k	US$160m
Sep 30 2019	n/a	n/a	US$155m
Jun 30 2019	n/a	n/a	US$154m
Mar 31 2019	n/a	n/a	US$152m
Dec 31 2018	US$2m	US$350k	US$154m
Sep 30 2018	n/a	n/a	US$155m
Jun 30 2018	n/a	n/a	US$153m
Mar 31 2018	n/a	n/a	US$154m
Dec 31 2017	US$2m	US$340k	US$159m

報酬と市場: D.の総報酬 ($USD 2.08M ) は、 US市場 ($USD 6.83M ) の同様の規模の企業の平均を下回っています。

報酬と収益: D.の報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

D. Mendelsohn (62 yo)

8.8yrs

在職期間

US$2,084,567

報酬

Mr. D. Eric Mendelsohn has been a Director at National Health Investors, Inc since February 17, 2021. Mr. Mendelsohn serves as the Chief Executive Officer and President at National Health Investors Inc. si...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
D. Mendelsohn	President	8.8yrs	US$2.08m	0.12% $ 3.7m
John Spaid	Executive VP of Finance	8.3yrs	US$1.30m	0.042% $ 1.2m
Kevin Pascoe	Executive VP & Chief Investment Officer	7.3yrs	US$1.19m	0.092% $ 2.7m
David Travis	Senior VP & Chief Accounting Officer	4.1yrs	US$1.02m	0.016% $ 471.2k
Kristin Gaines	Senior VP & Chief Transaction Officer	1.3yrs	US$1.05m	0.12% $ 3.5m
Dana Hambly	Director of Investor Relations	4.8yrs	データなし	データなし
Kimberly Ouimet	Director of Corporate Compliance & Human Resources	9.4yrs	データなし	データなし
Michelle Kelly	Senior Vice President of Investments	6.8yrs	データなし	データなし
Susan Sidwell	Corporate Secretary	no data	データなし	データなし
Colleen Schaller	Real Estate Transaction Manager	4.8yrs	データなし	データなし

6.8yrs

平均在職期間

52yo

平均年齢

経験豊富な経営陣: NHIの経営陣は経験豊富で経験豊富です（平均在職期間は6.8年）。

取締役

名称	ポジション	在職期間	報酬	所有権
D. Mendelsohn	President	3.3yrs	US$2.08m	0.12% $ 3.7m
W. Adams	Independent Chairman of the Board	33.4yrs	US$175.86k	1.97% $ 57.5m
Robert Adams	Independent Director	4.1yrs	US$175.86k	1.27% $ 37.1m
Charlotte Swafford	Independent Director	4.1yrs	US$175.86k	0.25% $ 7.4m
Robert McCabe	Independent Director	23.3yrs	US$190.86k	0.050% $ 1.5m
Robert Webb	Independent Director	33.4yrs	US$180.86k	0.24% $ 7.1m
Tracy M. Colden	Independent Director	2yrs	US$175.86k	0% $ 0
James Jobe	Independent Director	11.2yrs	US$180.86k	0.036% $ 1.0m

7.6yrs

平均在職期間

74.5yo

平均年齢

経験豊富なボード: NHIの取締役会は経験豊富であると考えられます ( 7.6年の平均在任期間)。

National Health Investors マネジメント

マネジメント 基準チェック /44

主要情報

経営陣の近況

National Health Investors, Inc., Annual General Meeting, May 22, 2024

Insufficient new directors

Independent Director recently bought US$587k worth of stock

Independent Director recently bought US$57k worth of stock

Chief Investment Officer exercised options and sold US$220k worth of stock

Independent Director recently bought US$99k worth of stock

Recent updates

Land & Buildings Investment Management Comments on National Health Investors’ Supplemental Proxy Statement

First quarter dividend of US$0.90 announced

National Health Investors: The Lack Of Upside Seems Obvious To Me Here

National Health Investors, Inc. Announces Dividend for the Second Quarter of 2024, Payable on August 2, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Land & Buildings Issues Letter to Shareholders of National Health Investors Announcing its Intention to Vote Against Two Directors at 2024 Annual Meeting

National Health Investors, Inc. to Report Q1, 2024 Results on May 06, 2024

National Health Investors, Inc., Annual General Meeting, May 22, 2024

Upcoming dividend of US$0.90 per share

Price target increased by 7.2% to US$62.00

Insufficient new directors

Independent Director recently bought US$587k worth of stock

Price target increased by 7.5% to US$59.86

Fourth quarter dividend of US$0.90 announced

National Health: Lots To Love, But Valuation Still On The High Side

Full year 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Provides Earnings Guidance for the Year 2024

National Health Investors, Inc. to Report Q4, 2023 Results on Feb 20, 2024

Upcoming dividend of US$0.90 per share at 6.3% yield

Catch The Senior Housing Rebound With National Health Investors

National Health Investors: 7% Yielding REIT Has Improved On Most Metrics

National Health Investors, Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors, Inc. Announces Its Fourth Quarter Dividend, Payable on January 26, 2024

National Health Investors, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Upcoming dividend of US$0.90 per share at 7.1% yield

National Health Investors: Enjoy This Solid 7%+ Yield, For Now

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

National Health Investors, Inc. Announces Third Quarter 2023 Dividend, Payable on November 3, 2023

National Health Investors, Inc. to Report Q2, 2023 Results on Aug 08, 2023

Upcoming dividend of US$0.90 per share at 6.8% yield

National Health: What We Got Wrong With This Healthcare REIT

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Second Quarter 2023 Dividend, Payable on August 4, 2023

Full year 2022 earnings: EPS misses analyst expectations

National Health Investors GAAP EPS of $0.04 misses by $0.65, revenue of $70.66M misses by $4.97M

6%-Yielding National Health Investors: No Pain, No Gain

National Health Investors, Inc. to Report Q4, 2022 Results on Feb 21, 2023

Upcoming dividend of US$0.90 per share

Independent Director recently bought US$57k worth of stock

National Health Investors, Inc. (NYSE:NHI) acquired Bickford of Virginia Beach from Bickford Senior Living, L.L.C. for $14 million.

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

National Health Investors, Inc. Announces Fourth Quarter 2022 Dividend, Payable on January 27, 2023

Consensus EPS estimates fall by 21%

National Health Investors, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Upcoming dividend of US$0.90 per share

National Health Investors: Why This 5.5%-Yielding Rebound Is Worth A Shot

Chief Investment Officer exercised options and sold US$220k worth of stock

Price target increased to US$62.71

Independent Director recently bought US$99k worth of stock

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

National Health Investors Q2 Earnings Preview

National Health Investors, Inc. to Report Q2, 2022 Results on Aug 08, 2022

National Health Investors: A 5.8% Yield, And Little Else

Upcoming dividend of US$0.90 per share

Consensus forecasts updated

National Health Investors, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

An unknown buyer acquired Two Assisted Living Facilities Located in Texas from National Health Investors, Inc. (NYSE:NHI) for $7.8 million.

National Health Investors, Inc. to Report Q1, 2022 Results on May 09, 2022

National Health Investors, Inc. (NYSE:NHI) announces an Equity Buyback for $240 million worth of its shares.

National Health Investors: Poor Price Growth, Steady Yield, Uncertain Future

Discovery Senior Living and National Health Investors, Inc. (NYSE:NHI) acquired 9-Community Independent Living Portfolio from Holiday AL Management Sub LLC.

Upcoming dividend of US$0.90 per share

National Health Investors, Inc. Declares First Quarter Dividend, Payable on May 6

An unknown buyer acquired Medical Office Building Located in Texas fromNational Health Investors, Inc. (NYSE:NHI) for approximately $5.1 million.

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

National Health Investors: Why This 7% Yielder Is A Buy On The Drop

マネジメント基準チェック /44